Medical Xpress·3 min read·medium
Maternal RSV vaccine cuts infant hospitalizations by 70%, study shows
✦AI Summary
A study published in JAMA Network Open reveals that the RSVpreF vaccine administered during pregnancy reduces infant hospitalizations by nearly 70%. This provides critical real-world evidence for the effectiveness of the vaccine in protecting newborns during their most vulnerable months.
Why it matters
RSV is a leading cause of infant hospitalization, and this vaccine offers a new, effective preventative measure for newborns.
edited by Sadie Harley , reviewed by Robert Egan
sciencehealth
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The article reports on peer-reviewed medical research and clinical data without political framing.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in